Cargando…

The Successful Use of Nitroglycerin for Uterine Hyperstimulation with Fetal Heart Rate Abnormality Caused by a Controlled-Release Dinoprostone Vaginal Delivery System (PROPESS): A Case Report

The PROPESS, a controlled-release dinoprostone vaginal delivery system, is a pharmacological cervical ripening intervention and promotes cervical change causing uterine contraction. During insertion of the PROPESS, uterine hyperstimulation could occur and result in fetal heart rate (FHR) abnormality...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takakura, Sho, Tanaka, Hiroaki, Enomoto, Naosuke, Maki, Shintaro, Ikeda, Tomoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151635/ https://www.ncbi.nlm.nih.gov/pubmed/34065827 http://dx.doi.org/10.3390/medicina57050478

Ejemplares similares

Placental growth factor level is correlated with intrapartum fetal heart rate findings
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

Comparison of Obstetric Outcomes Between Controlled-Release Dinoprostone Vaginal Delivery System (PROPESS) and Administration of Oral Dinoprostone for Labor Induction in Multiparous Women at Term
por: Yokoyama, Nobuko, et al.
Publicado: (2023)

Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction
por: Tsuchiya, Kyoka, et al.
Publicado: (2020)

Is there an interest in repeating the vaginal administration of dinoprostone (Propess®), to promote induction of labor of pregnant women at term? (RE-DINO): study protocol for a randomized controlled trial
por: Coste Mazeau, P., et al.
Publicado: (2020)

A Retrospective Comparative Study of the Effect of Controlled-Release Dinoprostone Vaginal Delivery System (Propess®) and Mechanical Methods for Cervical Ripening in Nulliparous Women in Late-Term Pregnancy
por: Shibata, Yoshie, et al.
Publicado: (2023)

Accurate evaluation of the progress of delivery with transperineal ultrasound may improve vaginal delivery: a single-center retrospective study
por: Enomoto, Naosuke, et al.
Publicado: (2023)

Evaluation of fetal acidemia during delivery using the conventional 5-tier classification and Rainbow systems
por: Magawa, Shoichi, et al.
Publicado: (2023)

Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction
por: Tsuji, Makoto, et al.
Publicado: (2023)

Appropriate Method of Administering Vasopressors for Maternal Hypotension Associated with Combined Spinal Epidural Anesthesia in Elective Cesarean Section: Impact on Postnatal Respiratory Support for Newborns
por: Magawa, Shoichi, et al.
Publicado: (2022)

Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction
por: Maki, Shintaro, et al.
Publicado: (2020)

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

Efficacy and safety of controlled‐release dinoprostone vaginal delivery system (PROPESS) in Japanese pregnant women requiring cervical ripening: Results from a multicenter, randomized, double‐blind, placebo‐controlled phase III study
por: Itoh, Hiroaki, et al.
Publicado: (2020)

Comparison of the Dinoprostone Vaginal Insert and Dinoprostone Tablet for the Induction of Labor in Primipara: A Retrospective Cohort Study
por: Ting, Ning-Shiuan, et al.
Publicado: (2022)

A Randomised Controlled Trial Comparing Induction of Labour with the Propess Vaginal System to the Prostin Vaginal Tablet in Premature Rupture of Membranes at Term
por: Anzeljc, Veronika, et al.
Publicado: (2022)

Prediction of an effective cervical ripenning in the induction of labour using vaginal dinoprostone
por: López Jiménez, Nuria, et al.
Publicado: (2023)

Misoprostol vs dinoprostone vaginal insert in labour induction: comparison of obstetrical outcome
por: Mlodawski, Jakub, et al.
Publicado: (2021)

Oral misoprostol, low dose vaginal misoprostol, and vaginal dinoprostone for labor induction: Randomized controlled trial
por: Young, David C., et al.
Publicado: (2020)

Mechanical cervicAl ripeninG for women with PrOlongedPregnancies (MAGPOP): protocol for a randomised controlled trial of a silicone double balloon catheter versus the Propess system for the slow release of dinoprostone for cervical ripening of prolonged pregnancies
por: Diguisto, Caroline, et al.
Publicado: (2017)

Comparative study of titrated oral misoprostol solution and vaginal dinoprostone for labor induction at term pregnancy
por: Wang, Xiu, et al.
Publicado: (2016)

Dinoprostone vaginal insert (DVI) versus adjunctive sweeping of membranes and DVI for term induction of labor
por: Bhatia, Anju, et al.
Publicado: (2021)

Dinoprostone Vaginal Insert for Induction of Labor in Women with Low-Risk Pregnancies: A Prospective Study
por: Anh, Nguyen Duy, et al.
Publicado: (2022)

Abnormal cardiovascular response to nitroglycerin in migraine
por: van Oosterhout, Willebrordus PJ, et al.
Publicado: (2019)

Induction of Labor at Term with Oral Misoprostol or as a Vaginal Insert and Dinoprostone Vaginal Insert – A Multicenter Prospective Cohort Study
por: Beyer, Jana, et al.
Publicado: (2022)

A mathematical model to predict mean time to delivery following cervical ripening with dinoprostone vaginal insert
por: Levast, Fanny, et al.
Publicado: (2019)

Comparison of Vaginal Dinoprostone Pessary With Transcervical Balloon Catheter Plus Vaginal Misoprostol for Pre-induction Cervical Ripening: A Randomized Trial
por: M, Kanagavarshani, et al.
Publicado: (2023)

Tadalafil Treatment of Mice with Fetal Growth Restriction and Preeclampsia Improves Placental mTOR Signaling
por: Tanaka, Kayo, et al.
Publicado: (2022)

Induction of Labor with Vaginal Dinoprostone (PGE(2)) in Patients with a Previous Cesarean Section: Obstetric and Neonatal Outcomes
por: López-Jiménez, Nuria, et al.
Publicado: (2021)

Comparing the effectiveness and safety of Dinoprostone vaginal insert and double-balloon catheter as cervical ripening treatments in Chinese patients
por: Yan, Jinjing, et al.
Publicado: (2022)

Maternal Blood Concentration of Tadalafil and Uterine Blood Flow in Pregnancy
por: Tanaka, Hiroaki, et al.
Publicado: (2019)

Vaginal, Cervical and Uterine pH in Women with Normal and Abnormal Vaginal Microbiota
por: Lykke, Malene Risager, et al.
Publicado: (2021)

Manipulative Reduction for Abnormal Uterine Inclination in Vaginal Delivery
por: Chen, Jia, et al.
Publicado: (2022)

Vaginal Dinoprostone Insert versus Cervical Ripening Balloon for Term Induction of Labor in Obese Nulliparas—A Randomized Controlled Trial
por: Lauterbach, Roy, et al.
Publicado: (2022)

Use of Vaginal Dinoprostone (PGE(2)) in Patients with Premature Rupture of Membranes (PROM) Undergoing Induction of Labor: A Comparative Study
por: López-Jiménez, Nuria, et al.
Publicado: (2022)

Nitroglycerine
Publicado: (1895)

Prediction of the induction to delivery time interval in vaginal dinoprostone-induced labor: a retrospective study in a Chinese tertiary maternity hospital
por: Zhao, Lei, et al.
Publicado: (2019)

Safety and efficacy of titrated oral misoprostol solution versus vaginal dinoprostone for induction of labor: A single‐center randomized control trial
por: Wang, Xiu, et al.
Publicado: (2021)

Double Balloon Catheter (Plus Oxytocin) versus Dinoprostone Vaginal Insert for Term Rupture of Membranes: A Randomized Controlled Trial (RUBAPRO)
por: Devillard, Eric, et al.
Publicado: (2022)

Reduction in resource use with the misoprostol vaginal insert vs the dinoprostone vaginal insert for labour induction: a model-based analysis from a United Kingdom healthcare perspective
por: Draycott, T., et al.
Publicado: (2016)

Cervical ripening in prolonged pregnancies by silicone double balloon catheter versus vaginal dinoprostone slow release system: The MAGPOP randomised controlled trial
por: Diguisto, Caroline, et al.
Publicado: (2021)

The Dose of Nitroglycerine
Publicado: (1892)

Cannot write session to /tmp/vufind_sessions/sess_7gs7to08llee070279ffsn23md